Analyst Research and Recommendations: Upland Software, Inc. (UPLD), Healthcare Services Group, Inc. (HCSG)

Upland Software, Inc. (NASDAQ:UPLD) tinted loss of -2.01% (-0.6 points) to US$29.2. The volume of 0.09 Million shares climbed down over an trading activity of 203.11 Million shares. EPS ratio determined by looking at last 12 month figures is -0.87. Over the same time span, the stock marked US$38.3 as its best level and the lowest price reached was US$20.95. The corporation has a market cap of US$627.59 Million.

Upland Software, Inc. (NASDAQ:UPLD)’s earnings per share has been growing at a -28.5 percent rate over the past 5 year when average revenue increase was noted as 33.9 percent. The return on equity ratio or ROE stands at -17.9 percent while most common profitability ratio return on investment (ROI) was -6.5 percent. The company’s institutional ownership is monitored at 70.7 percent. The company’s net profit margin has achieved the current level of -12.4 percent and possesses 67.5 percent gross margin.

Daily Analyst Recommendations

A number of key analysts, polled by FactSet, shared their views about the current stock momentum. The forecast of 2 surveyed investment analysts covering the stock advises investors to Buy stake in the company. At present, 0 analysts call it Sell, while 0 think it is Hold. Recently, analysts have updated the overall rating to 1.71. 5 analysts recommended Overweight these shares while 0 recommended Underweight, according to FactSet data.

Healthcare Services Group, Inc. (NASDAQ:HCSG) is worth US$3.27 Billion and has recently fallen -1.18% to US$43.57. The latest exchange of 0.29 Million shares is below its average trading activity of 587.26 Million shares. The day began at US$0 but the price moved to US$0 at one point during the trading and finally capitulating to a session high of US$0. The stock tapped a 52-week high of US$56.17 while the mean 12-month price target for the shares is US$47.78.

Currently, the stock carries a price to earnings ratio of 42.89, a price to book ratio of 7.78, and a price to sales ratio of 1.63. For the past 5 years, the company’s revenue has grown 11.6%, while the company’s earnings per share has grown 14.1%. With an institutional ownership near 0%, it carries an earnings per share ratio of 1.03.

Inside Look At Analysts Reviews

Latest analyst recommendations could offer little help to investors. The stock is a Buy among 6 brokerage firms polled by Factset Research. At present, 2 analysts recommended Holding these shares while 1 recommended sell, according to FactSet data. 0 analysts call it Underweight, while 1 think it is Overweight. Recently, investment analysts covering the stock have updated the mean rating to 1.9.